Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mitzi, Lewellen"'
Autor:
Rose H. Dicovitsky, Jill T. Schappa, Ashley J. Schulte, Haeree P. Lang, Ellen Kuerbitz, Sarah Roberts, Taylor A. DePauw, Mitzi Lewellen, Amber L. Winter, Kathy Stuebner, Michelle Buettner, Kelly Reid, Kelly Bergsrud, Sara Pracht, Andrea Chehadeh, Caitlin Feiock, M. Gerard O’Sullivan, Tim Carlson, Alexandra R. Armstrong, Danielle Meritet, Michael S. Henson, Brenda J. Weigel, Jaime F. Modiano, Antonella Borgatti, Daniel A. Vallera
Publikováno v:
Toxins, Vol 16, Iss 9, p 376 (2024)
EGFR-targeted therapies are efficacious, but toxicity is common and can be severe. Urokinase type plasminogen activator receptor (uPAR)-targeted drugs are only emerging, so neither their efficacy nor toxicity is fully established. Recombinant eBAT wa
Externí odkaz:
https://doaj.org/article/6505ce6cd7b5471f92672f457ebc37f6
Autor:
Kerstin Lindblad-Toh, Ingegerd Elvers, Jaime F. Modiano, Matthew Breen, Elinor K. Karlsson, Rachael Thomas, Corrie Painter, Jessica Alfoldi, Noriko Tonomura, Luke Borst, Ashley J. Schulte, Milcah C. Scott, Mitzi Lewellen, Michele Koltookian, Jeremy Johnson, Sharadha Sakthikumar, Chao Wang, Aaron L. Sarver, Jong-Hyuk Kim, Ross Swofford, Jason Turner-Maier, Kate Megquier
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c32caa37ff058953d7c8963ec184eda
https://doi.org/10.1158/1541-7786.22515477.v1
https://doi.org/10.1158/1541-7786.22515477.v1
Autor:
Kerstin Lindblad-Toh, Ingegerd Elvers, Jaime F. Modiano, Matthew Breen, Elinor K. Karlsson, Rachael Thomas, Corrie Painter, Jessica Alfoldi, Noriko Tonomura, Luke Borst, Ashley J. Schulte, Milcah C. Scott, Mitzi Lewellen, Michele Koltookian, Jeremy Johnson, Sharadha Sakthikumar, Chao Wang, Aaron L. Sarver, Jong-Hyuk Kim, Ross Swofford, Jason Turner-Maier, Kate Megquier
Table S1. Canine cohort metadata Table S2. Canine library preparation, amplification, and complexity Table S3. COSMIC Cancer Gene Census genes Table S4. Summary of canine RNA-seq data Table S5. RNA-seq validation Table S6. RNA-seq survey Table S7. En
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8e0170833c99fa01b267c8b24042e9
https://doi.org/10.1158/1541-7786.22515474.v1
https://doi.org/10.1158/1541-7786.22515474.v1
Autor:
Kerstin Lindblad-Toh, Ingegerd Elvers, Jaime F. Modiano, Matthew Breen, Elinor K. Karlsson, Rachael Thomas, Corrie Painter, Jessica Alfoldi, Noriko Tonomura, Luke Borst, Ashley J. Schulte, Milcah C. Scott, Mitzi Lewellen, Michele Koltookian, Jeremy Johnson, Sharadha Sakthikumar, Chao Wang, Aaron L. Sarver, Jong-Hyuk Kim, Ross Swofford, Jason Turner-Maier, Kate Megquier
Supplemental Table 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03fdd0526168cadefc71269476da7449
https://doi.org/10.1158/1541-7786.22515480.v1
https://doi.org/10.1158/1541-7786.22515480.v1
Autor:
Kerstin Lindblad-Toh, Ingegerd Elvers, Jaime F. Modiano, Matthew Breen, Elinor K. Karlsson, Rachael Thomas, Corrie Painter, Jessica Alfoldi, Noriko Tonomura, Luke Borst, Ashley J. Schulte, Milcah C. Scott, Mitzi Lewellen, Michele Koltookian, Jeremy Johnson, Sharadha Sakthikumar, Chao Wang, Aaron L. Sarver, Jong-Hyuk Kim, Ross Swofford, Jason Turner-Maier, Kate Megquier
Angiosarcoma is a highly aggressive cancer of blood vessel–forming cells with few effective treatment options and high patient mortality. It is both rare and heterogenous, making large, well-powered genomic studies nearly impossible. Dogs commonly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0229b663319dc1dc3ceeea0bd2c1725
https://doi.org/10.1158/1541-7786.c.6541095
https://doi.org/10.1158/1541-7786.c.6541095
Autor:
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O’Brien, Michael Henson, Antonella Borgatti, Mitzi Lewellen, Erika Krick, Jane Stewart, Sarah Lahrman, Bartek Rajwa, Milcah C Scott, Davis Seelig, Joseph Koopmeiners, Stephan Ruetz, Jaime Modiano
Publikováno v:
F1000Research, Vol 4 (2017)
We previously described a population of lymphoid progenitor cells (LPCs) in canine B-cell lymphoma defined by retention of the early progenitor markers CD34 and CD117 and “slow proliferation” molecular signatures that persist in the xenotransplan
Externí odkaz:
https://doaj.org/article/a214a949e7134dbb8adc9bb8582da898
Autor:
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O’Brien, Michael Henson, Antonella Borgatti, Mitzi Lewellen, Erika Krick, Jane Stewart, Sarah Lahrman, Bartek Rajwa, Milcah C Scott, Davis Seelig, Joseph Koopmeiners, Stephan Ruetz, Jaime Modiano
Publikováno v:
F1000Research, Vol 4 (2017)
We previously described a population of lymphoid progenitor cells (LPCs) in canine B-cell lymphoma defined by retention of the early progenitor markers CD34 and CD117 and “slow proliferation” molecular signatures that persist in the xenotransplan
Externí odkaz:
https://doaj.org/article/8099bd2db3d94f6d996734d884a57625
Autor:
Sarah L May, Qing Zhou, Mitzi Lewellen, Cristan M Carter, David Coffey, Steven L Highfill, Christoph M Bucher, Ilze Matise, Herbert C Morse, M Gerard O'Sullivan, Melissa Schutten, Charles Johnson, Donald Bellgrau, Bruce R Blazar, Jaime F Modiano
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100629 (2014)
Nfatc2 and Tob1 are intrinsic negative regulators of T cell activation. Nfatc2-deficient and Tob1-deficient T cells show reduced thresholds of activation; however, whether these factors have independent or overlapping roles in negative regulation of
Externí odkaz:
https://doaj.org/article/f2fad48460fd4901b6228b78d493c185
Autor:
Sharadha Sakthikumar, Rachael Thomas, Aaron L. Sarver, Jessica Alföldi, Ingegerd Elvers, Luke B. Borst, Jaime F. Modiano, Mitzi Lewellen, Ashley J. Graef, Chao Wang, Elinor K. Karlsson, Jong Hyuk Kim, Kate Megquier, Noriko Tonomura, Kerstin Lindblad-Toh, Milcah C. Scott, Ross Swofford, Matthew Breen, Jason Turner-Maier, Corrie A. Painter, Jeremy Johnson, Michele Koltookian
Angiosarcoma is a highly aggressive cancer of blood vessel-forming cells with high fatality and few effective treatment options. It is both rare and heterogenous, making large, well powered genomic studies nearly impossible. In dogs, angiosarcoma is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad24e432acc772f0d31622a5a3e390ab
https://doi.org/10.1101/570879
https://doi.org/10.1101/570879
Autor:
Kate, Megquier, Jason, Turner-Maier, Ross, Swofford, Jong-Hyuk, Kim, Aaron L, Sarver, Chao, Wang, Sharadha, Sakthikumar, Jeremy, Johnson, Michele, Koltookian, Mitzi, Lewellen, Milcah C, Scott, Ashley J, Schulte, Luke, Borst, Noriko, Tonomura, Jessica, Alfoldi, Corrie, Painter, Rachael, Thomas, Elinor K, Karlsson, Matthew, Breen, Jaime F, Modiano, Ingegerd, Elvers, Kerstin, Lindblad-Toh
Publikováno v:
Mol Cancer Res
Angiosarcoma is a highly aggressive cancer of blood vessel-forming cells with few effective treatment options and high patient mortality. It is both rare and heterogenous, making large, well powered genomic studies nearly impossible. Dogs commonly su